Skip to main content
main-content

12-09-2019 | Multiple sclerosis | Video

ECTRIMS 2019: Myelin-specific CD8+ T-cell activation increased in MS

Joseph Sabatino discusses research showing a unique multiple sclerosis phenotype in the form of increased myelin-specific CD8+ T-cell activation and a role for anti-CD20 therapy (5:15).

Funding for independent interviews at ECTRIMS 2019 was provided by F.Hoffmann-La Roche Ltd, Basel, Switzerland.